| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | AMICUS THERAPEUTICS INC | 15,239,444 | 147,823,000 | 10.94% | ||
| 2 | NEUROCRINE BIOSCIE COM USD0.001 | 2,496,167 | 141,208,000 | 10.45% | ||
| 3 | SAREPTA THERAPEUTICS INC | 2,240,928 | 86,455,000 | 6.40% | ||
| 4 | DYAX CORP COM CVR | 1,819,215 | 68,439,000 | 5.06% | ||
| 5 | TESARO INC | 968,659 | 50,680,000 | 3.75% | ||
| 6 | RETROPHIN INC COM | 2,579,380 | 49,756,000 | 3.68% | ||
| 7 | ALLERGAN PLC | 145,000 | 45,313,000 | 3.35% | ||
| 8 | GLOBAL BLOOD THERAPEUTICS IN COM | 1,186,630 | 38,363,000 | 2.84% | ||
| 9 | NEVRO CORP | 484,279 | 32,694,000 | 2.42% | ||
| 10 | TEVA PHARMACEUTICAL INDS LTD | 481,000 | 31,573,000 | 2.34% | ||
| 11 | VERSARTIS INC COM | 2,299,454 | 28,490,000 | 2.11% | ||
| 12 | GW PHARMACEUTICALS PLC | 400,000 | 27,776,000 | 2.06% | Put | |
| 13 | XENCOR INC COM | 1,854,784 | 27,117,000 | 2.01% | ||
| 14 | IGNYTA INC COM | 1,812,060 | 24,282,000 | 1.80% | ||
| 15 | Lion Biotechnologies | 3,000,161 | 23,161,000 | 1.71% | ||
| 16 | ACELRX PHARMACEUTICALS INC | 5,995,760 | 23,084,000 | 1.71% | ||
| 17 | SAREPTA THERAPEUTICS INC | 500,000 | 19,290,000 | 1.43% | Call | |
| 18 | Baxter Intl Inc | 485,000 | 18,503,000 | 1.37% | ||
| 19 | FIVE PRIME THERAPEUTICS INC | 434,129 | 18,016,000 | 1.33% | ||
| 20 | APPLIED GENETIC TECHNOL CORP | 861,513 | 17,575,000 | 1.30% | ||
| 21 | LA JOLLA PHARMACEUTICAL CO | 649,515 | 17,537,000 | 1.30% | ||
| 22 | DERMIRA INC | 502,000 | 17,374,000 | 1.29% | ||
| 23 | UNIQURE NV | 967,093 | 15,996,000 | 1.18% | ||
| 24 | QUOTIENT LTD | 893,540 | 14,297,000 | 1.06% | ||
| 25 | VERTEX PHARMACEUT | 110,000 | 13,841,000 | 1.02% | ||
| 26 | ACCELERON PHARMA | 276,036 | 13,460,000 | 1.00% | ||
| 27 | CYTOMX THERAPEUTICS INC COM | 642,047 | 13,399,000 | 0.99% | ||
| 28 | REGENXBIO INC COM | 779,213 | 12,934,000 | 0.96% | ||
| 29 | CIDARA THERAPEUTICS INC | 742,858 | 12,747,000 | 0.94% | ||
| 30 | PFENEX INC COM | 960,877 | 11,896,000 | 0.88% | ||
| 31 | EAGLE PHARMACEUTICALS INC COM | 133,145 | 11,806,000 | 0.87% | ||
| 32 | DBV TECHNOLOGIES | 306,715 | 11,137,000 | 0.82% | ||
| 33 | BLUEPRINT MEDICINES CORP COM | 404,404 | 10,652,000 | 0.79% | ||
| 34 | CAPITAL SR LIVING CORP COM | 483,700 | 10,090,000 | 0.75% | ||
| 35 | AXOVANT SCIENCES LTD | 535,000 | 9,646,000 | 0.71% | ||
| 36 | DEPOMED INC | 500,000 | 9,065,000 | 0.67% | ||
| 37 | ACADIA PHARMACEUTICALS | 245,240 | 8,743,000 | 0.65% | ||
| 38 | BELLICUM PHARMACEUTICALS INC | 421,188 | 8,537,000 | 0.63% | ||
| 39 | ALDEYRA THERAPEUTICS INC | 1,240,458 | 8,410,000 | 0.62% | ||
| 40 | AMGEN INC | 50,000 | 8,117,000 | 0.60% | ||
| 41 | VBI Vaccines Inc. | 3,260,356 | 7,955,000 | 0.59% | ||
| 42 | ONCOTHYREON INC COM N/C EFF 6/ | 3,414,121 | 7,579,000 | 0.56% | ||
| 43 | ANI PHARMACEUTICALS INC | 7,500,000 | 7,461,000 | 0.55% | PRN | |
| 44 | MYOKARDIA INC | 502,903 | 7,372,000 | 0.55% | ||
| 45 | NEPTUNE TECHNOLOGIES BIORESO | 6,700,444 | 7,169,000 | 0.53% | ||
| 46 | ALCOBRA LTD | 1,028,272 | 6,458,000 | 0.48% | ||
| 47 | AFFIMED N V | 868,820 | 6,186,000 | 0.46% | ||
| 48 | ASSEMBLY BIOSCIENCES INC | 795,000 | 5,970,000 | 0.44% | ||
| 49 | ABEONA THERAPEUTICS INC | 1,762,881 | 5,923,000 | 0.44% | ||
| 50 | ARDELYX INC | 315,955 | 5,725,000 | 0.42% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001019056-16-001109, filed 2016.02.16).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
